RECRUITING

Cannabis Use and Outcomes in Black and White Patients With Cancer

Description

The goal of the observational study is to learn how black and white patients with solid tumor cancer use cannabis, opioids and tobacco. The investigators are using momentary ecological assessment through a smart phone app and surveys to assess patient-reported pain and other symptoms as to inform clinical practice and guidelines for underrepresented populations.

Conditions

Study Overview

Study Details

Study overview

The goal of the observational study is to learn how black and white patients with solid tumor cancer use cannabis, opioids and tobacco. The investigators are using momentary ecological assessment through a smart phone app and surveys to assess patient-reported pain and other symptoms as to inform clinical practice and guidelines for underrepresented populations.

Cannabis Use and Outcomes in Black and White Patients With Cancer

Cannabis Use and Outcomes in Black and White Patients With Cancer

Condition
Cancer
Intervention / Treatment

-

Contacts and Locations

Buffalo

University at Buffalo, Buffalo, New York, United States, 14214

Philadelphia

Thomas Jefferson University, Philadelphia, Pennsylvania, United States, 19144

Philadelphia

University of Pennsylvania, Philadelphia, Pennsylvania, United States, 19176

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 21 years or older
  • * Black or white race
  • * Solid tumor cancer within 3 years of enrollment
  • * Cannabis use of at least once a week or non cannabis use for 3 months
  • * experience pain but spend less than 50% in bed or chair
  • * Prescribed or take opioid for at least 30 days for pain
  • * Not pregnant or planning to become pregnant in the next 12 months
  • * English speaking
  • * Lymphoma, leukemia, and melanoma
  • * CBD only use
  • * Synthetic cannabis use in past 3 months = Prescribed Medically-prescribed synthetic cannabis (e.g., dronabinol \[Marinol, Syndros\], Epidiolex)
  • * race other than Black or White

Ages Eligible for Study

21 Years to 99 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

State University of New York at Buffalo,

Salimah Meghani, PhD, PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Brooke Worster, MD, PRINCIPAL_INVESTIGATOR, Thomas Jefferson University

Rebecca L Ashare, PhD, PRINCIPAL_INVESTIGATOR, University at Buffalo

Study Record Dates

2027-03-30